Molecular and clinical response to angiotensin II receptor antagonist in kidney transplant patients with chronic allograft nephropathy

Transplant International

Volumn 17, Issue 9, 2004, Pages 540-544

  Mas, Valeria R ^a   Alvarellos, Teresita ^b   Maluf, Daniel G ^a   Ferreira Gonzalez, Andrea ^a   Oliveros, Liliana ^d   Maldonado, Rafael A ^c   De Boccardo, Graciela ^c  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b HOSPITAL PRIVADO   (Argentina)

^c Clinica Privada Velez Sarsfield Cordoba   (Argentina)

^d UNIVERSIDAD NACIONAL DE SAN LUIS   (Argentina)

Author keywords

Angiotensin II; Angiotensin II receptor antagonist; Chronic allograft nephropathy; Kidney transplantation; Losartan; TGF 1

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; AZATHIOPRINE; CORTICOSTEROID DERIVATIVE; CYCLOSPORIN; LOSARTAN; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GRAFT REJECTION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; CHRONIC DISEASE; FEMALE; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LOSARTAN; MALE; MIDDLE AGED; PROTEINURIA; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 9944224312     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00147-004-0740-5     Document Type: Article

References (11)

1. Paul LC. Chronic allograft nephropathy: an update. Kidney Int 1999; 56:783
2. Colvin R, Chase C, Winn H, Russell P. Chronic allograft arteriopathy: insights from experimental models. In: Orosz C, Sedmak D, Ferguson R (eds) Transplant vascular sclerosis. Landes, Austin, 1995; pp 7-33
3. Pankewycz O. Transforming growth factor β and renal graft fibrosis. Curr Opin Organ Transplant 2000; 5:336
4. Kagami S, Border W, Miller D, Noble NA. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β1 expression in rat glomerular mesangial cells. J Clin Invest 1994; 93:2431
5. Mas V, Diller A, Albano S, et al. Intragraft expression of transforming growth factor (TGFβ1) in kidney transplant recipients. Transplantation 2000; 70:612
6. Mas V, Alvarellos T, Giraudo C, Massari P, De Boccardo G. Intragraft messenger RNA expression of angiotensinogen: relationship with transforming growth factor beta-1 and chronic allograft nephropathy in kidney transplant patients. Transplantation 2002; 74:718
7. Racusen L, C, Solez K, Colvin R, B et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55:713
8. Regiment P, Schlepped A, Remiss G. Progression, remission, regression of chronic renal diseases. Lancet 2001; 357:1601
9. Roodnat JI, Mulder PG, Rischen-Vos J, et al. Proteinuria after renal transplantation affects not only graft survival but also patient survival. Transplantation 2001; 72:438
10. Khanna A, Plummer M, Bromberek C, Bresnahan B, Hariharan S. Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity. Kidney Int 2002; 62:2257
11. Campistol JM, Inigo P, Jimenez W, et al. Losartan decreases plasma levels of TGF-beta1 in transplant patients with chronic allograft nephropathy. Kidney Int 1999; 56:714